{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T05:50:57Z","timestamp":1791438657356,"version":"4.3.3"},"reference-count":29,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2006,2,1]],"date-time":"2006-02-01T00:00:00Z","timestamp":1138752000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2006,2]]},"DOI":"10.1002\/jps.20553","type":"journal-article","created":{"date-parts":[[2005,12,22]],"date-time":"2005-12-22T22:20:28Z","timestamp":1135290028000},"page":"372-383","source":"Crossref","is-referenced-by-count":85,"title":["Intraluminal drug and formulation behavior and integration in in vitro permeability estimation: A case study with amprenavir"],"prefix":"10.1016","volume":"95","author":[{"given":"Joachim","family":"Brouwers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Tack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Lammert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Augustijns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1002\/jps.20553_bb0010","first-page":"75","article-title":"Influence of physicochemical properties on dissolution of drugs in the gastrointestinal tract","volume":"46","author":"Horter","year":"2001","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1002\/jps.20553_bb0015","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1023\/A:1007576713216","article-title":"A comparison of the solubility of danazol in human and simulated gastrointestinal fluids","volume":"17","author":"Pedersen","year":"2000","journal-title":"Pharm Res"},{"key":"10.1002\/jps.20553_bb0020","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2174\/1389200043489144","article-title":"Intestinal drug transporters: In vivo function and clinical importance","volume":"5","author":"Kunta","year":"2004","journal-title":"Curr Drug Metab"},{"key":"10.1002\/jps.20553_bb0025","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1002\/jps.10408","article-title":"Biological, pharmaceutical, and analytical considerations with respect to the transport media used in the absorption screening system, Caco-2","volume":"92","author":"Ingels","year":"2003","journal-title":"J Pharm Sci"},{"key":"10.1002\/jps.20553_bb0030","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0928-0987(00)00076-2","article-title":"Optimized conditions for prediction of intestinal drug permeability using Caco-2 cells","volume":"10","author":"Yamashita","year":"2000","journal-title":"Eur J Pharm Sci"},{"key":"10.1002\/jps.20553_bb0035","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1023\/A:1025032511040","article-title":"pH-dependent bidirectional transport of weakly basic drugs across Caco-2 monolayers: Implications for drug-drug interactions","volume":"20","author":"Neuhoff","year":"2003","journal-title":"Pharm Res"},{"key":"10.1002\/jps.20553_bb0040","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1002\/jps.10158","article-title":"Examination of the solubilization of drugs by bile salt micelles","volume":"91","author":"Wiedmann","year":"2002","journal-title":"J Pharm Sci"},{"key":"10.1002\/jps.20553_bb0045","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0378-5173(01)00897-3","article-title":"Simulated intestinal fluid as transport medium in the Caco-2 cell culture model","volume":"232","author":"Ingels","year":"2002","journal-title":"Int J Pharm"},{"key":"10.1002\/jps.20553_bb0050","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1023\/A:1013699130991","article-title":"Transport activity of human MRP3 expressed in Sf9 cells: Comparative studies with rat MRP3","volume":"19","author":"Akita","year":"2002","journal-title":"Pharm Res"},{"key":"10.1002\/jps.20553_bb0055","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ijpharm.2004.01.014","article-title":"Effect of simulated intestinal fluid on drug permeability estimation across Caco-2 monolayers","volume":"274","author":"Ingels","year":"2004","journal-title":"Int J Pharm"},{"key":"10.1002\/jps.20553_bb0060","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1023\/B:PHAM.0000016235.32639.23","article-title":"Solubilizing excipients in oral and injectable formulations","volume":"21","author":"Strickley","year":"2004","journal-title":"Pharm Res"},{"key":"10.1002\/jps.20553_bb0065","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0928-0987(02)00055-6","article-title":"Effects of nonionic surfactants on membrane transporters in Caco-2 cell monolayers","volume":"16","author":"Rege","year":"2002","journal-title":"Eur J Pharm Sci"},{"key":"10.1002\/jps.20553_bb0070","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0939-6411(00)00113-2","article-title":"Effect of solubilizing excipients on permeation of poorly water-soluble compounds across Caco-2 cell monolayers","volume":"50","author":"Saha","year":"2000","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1002\/jps.20553_bb0075","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0378-5173(02)00347-2","article-title":"Common solubilizers to estimate the Caco-2 transport of poorly water-soluble drugs","volume":"246","author":"Takahashi","year":"2002","journal-title":"Int J Pharm"},{"key":"10.1002\/jps.20553_bb0080","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1211\/0022357056631","article-title":"Determination of intraluminal theophylline concentrations after oral intake of an immediate- and a slow-release dosage form","volume":"57","author":"Brouwers","year":"2005","journal-title":"J Pharm Pharmacol"},{"key":"10.1002\/jps.20553_bb0085","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1023\/A:1018939006780","article-title":"Vitamin E-TPGS increases absorption flux of an HIV protease inhibitor by enhancing its solubility and permeability","volume":"16","author":"Yu","year":"1999","journal-title":"Pharm Res"},{"key":"10.1002\/jps.20553_bb0090","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1023\/A:1018941328702","article-title":"Role of P-glycoprotein on the CNS disposition of amprenavir (141W94), an HIV protease inhibitor","volume":"16","author":"Polli","year":"1999","journal-title":"Pharm Res"},{"key":"10.1002\/jps.20553_bb0095","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1128\/AAC.43.8.1817","article-title":"Antiretroviral-drug concentrations in semen: Implications for sexual transmission of human immunodeficiency virus type 1","volume":"43","author":"Kashuba","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1002\/jps.20553_bb0100","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1023\/A:1011910801212","article-title":"Evaluation of various dissolution media for predicting in vivo performance of class I and II drugs","volume":"15","author":"Galia","year":"1998","journal-title":"Pharm Res"},{"key":"10.1002\/jps.20553_bb0105","first-page":"A98","article-title":"Evaluation and clinical application of a novel, sensitive HPLC-ESI-tandem MS\/MS method for quantification of 11 different bile acids in human serum","volume":"41","author":"Krichherr","year":"2003","journal-title":"Clin Chem Lab Med"},{"key":"10.1002\/jps.20553_bb0110","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S0022-2275(20)35380-3","article-title":"Enzymatic measurement of choline-containing phospholipids in bile","volume":"22","author":"Gurantz","year":"1981","journal-title":"J Lipid Res"},{"key":"10.1002\/jps.20553_bb0115","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1023\/A:1015000503629","article-title":"Inhibition of P-glycoprotein by D-alpha-tocopheryl polyethylene glycol 1000 succinate (TPGS)","volume":"16","author":"Dintaman","year":"1999","journal-title":"Pharm Res"},{"key":"10.1002\/jps.20553_bb0120","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.clpt.2004.09.001","article-title":"P-glycoprotein and surfactants: Effect on intestinal talinolol absorption","volume":"77","author":"Bogman","year":"2005","journal-title":"Clin Pharmacol Ther"},{"key":"10.1002\/jps.20553_bb0125","first-page":"1875","article-title":"Use of water-soluble liquid vitamin E to enhance cyclosporine absorption in children after liver transplant","volume":"25","author":"Boudreaux","year":"1993","journal-title":"Transplant Proc"},{"key":"10.1002\/jps.20553_bb0130","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0009-9236(96)80007-5","article-title":"The effect of water-soluble vitamin E on cyclosporine pharmacokinetics in healthy volunteers","volume":"59","author":"Chang","year":"1996","journal-title":"Clin Pharmacol Ther"},{"key":"10.1002\/jps.20553_bb0135","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1023\/A:1023891320858","article-title":"P-glycoprotein attenuating effect of human intestinal fluid","volume":"20","author":"Deferme","year":"2003","journal-title":"Pharm Res"},{"key":"10.1002\/jps.20553_bb0140","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1023\/A:1011984216775","article-title":"Dissolution testing as a prognostic tool for oral drug absorption: Immediate release dosage forms","volume":"15","author":"Dressman","year":"1998","journal-title":"Pharm Res"},{"key":"10.1002\/jps.20553_bb0145","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1023\/A:1012107801889","article-title":"Characterization of fluids from the stomach and proximal jejunum in men and women","volume":"14","author":"Lindahl","year":"1997","journal-title":"Pharm Res"},{"key":"10.1002\/jps.20553_bb0150","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1093\/ajcn\/64.3.329","article-title":"Plasma alpha-tocopherol concentrations after supplementation with water- and fat-soluble vitamin E","volume":"64","author":"Dimitrov","year":"1996","journal-title":"Am J Clin Nutr"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002235491631944X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002235491631944X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,7,21]],"date-time":"2021-07-21T22:34:59Z","timestamp":1626906899000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002235491631944X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,2]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,2]]}},"alternative-id":["S002235491631944X"],"URL":"https:\/\/doi.org\/10.1002\/jps.20553","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2006,2]]}}}